- Pharmacological Treatment vs Psychotherapy: This dilemma involves choosing between pharmacological treatments (e.g. medication) and psychotherapy (e.g. cognitive behavioral therapy). Medications might provide quick symptom relief, but come with potential side effects and dependence issues. Psychotherapy is generally safer but requires substantial commitment and may not provide immediate relief. This decision-making process can be challenging, requiring careful assessment of the patient’s condition, personal preferences, and potential risks of each approach.Consequences: Choosing one over the other may lead to suboptimal outcomes. For instance, reliance on medication may lead to inadequate management of root psychological issues, while psychotherapy alone may prolong suffering if the condition is severe and responds well to medication.
- Confidentiality and Mandatory Reporting: If a patient’s symptoms suggest they may be a danger to themselves or others, the healthcare provider faces a dilemma between maintaining patient confidentiality and reporting to authorities.Consequences: If confidentiality is breached, this could damage the therapeutic alliance, potentially discouraging the patient from seeking further help. Yet, if risks are not reported, it may lead to harm for the patient or others.
- Informed Consent in Cognitive Impairment: Patients with functional neurological disorders may also have cognitive impairments. This presents a challenge in obtaining informed consent for treatment.Consequences: Administering treatment without proper consent may violate the patient’s rights and autonomy. Conversely, not treating a patient because they’re unable to give informed consent might prevent them from receiving necessary care, leading to deteriorating health conditions.
Unveiling the Impact of Prior Beliefs on the Development of Functional Neurological Disorder and Prolonged Post-Concussion Syndrome: A Bayesian Perspective